Tumor Cells
10.1038/s41523-019-0106-x

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients


Tumor Cells
10.3390/jcm8071011

Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab


Tumor Cells
10.15761/fnn.1000186

Curcumin nanocrystallites are an ideal nanoplatform for cancer chemotherapy


Tumor Cells
10.1186/s13072-019-0286-5

BRD4 bimodal binding at promoters and drug-induced displacement at Pol II pause sites associates with I-BET sensitivity


Tumor Cells
10.1007/s12011-019-01976-0

Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action


Tumor Cells
10.1021/jacs.8b10207

CRIF1-CDK2 Interface Inhibitors: An Unprecedented Strategy for Modulation of Cell Radiosensitivity.


Tumor Cells
10.1080/07391102.2018.1461133

Exploring movement and energy in human P-glycoprotein conformational rearrangement


Tumor Cells
10.1158/2326-6074.CRICIMTEATIAACR18-A154

Abstract A154: Flow cytometric analysis of immune responses in the melanoma tissue biopsies before or during anti-PD1 immunotherapy


Tumor Cells
10.1158/1538-7445.AM2019-4972

Abstract 4972: Preclinical development of a first-in-class NKp30xBCMA NK cell engager for the treatment of multiple myeloma


Tumor Cells
10.13345/j.cjb.190300

[Function of tumor infiltrating lymphocytes in solid tumors - a review].


Tumor Cells
10.33545/PATHOL.2019.V2.I1C.25

Evaluation of clinicopathologic significance of tumor budding in breast carcinoma


Tumor Cells
10.1002/rcm.8551

Identification of novel biomarkers of hepatocellular carcinoma by a high definition mass spectrometry; UHPLC-QTOF/MS and DESI-MSI.


Tumor Cells
10.1016/j.celrep.2019.10.093

A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.


Tumor Cells
10.1016/j.jinorgbio.2019.110751

Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells.


Tumor Cells
10.1016/J.LUNGCAN.2019.03.029

Patients with SMARCA4-deficient thoracic sarcoma and severe skeletal-related events.


Tumor Cells
10.3390/pharmaceutics11110584

Fabrication of Ion-Crosslinking Aminochitosan Nanoparticles for Encapsulation and Slow Release of Curcumin


Tumor Cells
10.32604/mcb.2019.07111

Numerical Analysis of Motion and Stress Distribution of Circulating Tumor Cells in Micro Vessels


Tumor Cells
10.3390/ijms20194693

EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells


Tumor Cells
10.1016/j.biopha.2019.109557

ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D.


Tumor Cells
10.1371/journal.pone.0212321

The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner


Tumor Cells
10.1002/ima.22295

A novel prognosis and segmentation of necrosis (dead cells) in contrast enhanced T1‐weighted glioblastoma tumor with automatic contextual clustering


Tumor Cells
10.1101/805655

Modulating Sphingosine-1-Phosphate receptors to improve chemotherapy delivery to Ewing sarcoma


Tumor Cells
10.1093/annonc/mdz239.026

Evaluation of microsatellite instability testing through cell-free DNA sequencing


Tumor Cells
10.1093/annonc/mdz268.088

Novel polyurea/polyurethane nanocapsules loaded with a tambjamine analog to improve cancer chemotherapy delivery and safety in lung cancer


Tumor Cells
10.1021/acs.biomac.9b00101

Synthesis of an Oxidation-Sensitive Polyphosphoester Bearing Thioether Group for Triggered Drug Release.


Tumor Cells
10.21294/1814-4861-2019-18-1-71-78

Асцитная опухоль яичников у крыс – адекватная доклиническая модель канцероматоза для изучения интраперитонеального химиоперфузионного лечения


Tumor Cells
10.4103/jcar.JCar_24_18

Assessment and clinicopathological correlation of matrix metalloproteinase 9 expression in nasopharyngeal carcinoma


Tumor Cells
10.1117/12.2507271

Label-free imaging of cancer cells by in-flow tomography


Tumor Cells
10.1186/s40425-019-0709-7

Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma


Tumor Cells
10.1096/fj.201801936RRR

TANK‐binding kinase 1 is a mediator of platelet‐induced EMT in mammary carcinoma cells


Tumor Cells
10.31487/J.RDI.2019.02.03

Radiosensitizing performance of uncoated and citrate-coated SPIONs in cancerous and non-cancerous cells


Tumor Cells
10.1080/2162402X.2019.1644108

Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens


Tumor Cells
10.1016/b978-0-12-801238-3.11239-5

Tumor dormancy in the bone


Tumor Cells
10.3892/ol.2019.11047

Detection of circulating colorectal cancer cells by a custom microfluid system before and after endoscopic metallic stent placement


Tumor Cells
10.3389/fimmu.2019.00954

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer


Tumor Cells
10.1080/2162402X.2018.1553478

A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo


Tumor Cells
10.1158/1538-7445.SABCS18-GS3-07

Abstract GS3-07: Clinical utility of circulating tumor cell count as a tool to chose between first line hormone therapy and chemotherapy for ER+ HER2- metastatic breast cancer: Results of the phase III STIC CTC trial


Tumor Cells
10.1155/2019/1407167

Methylation Changes of Primary Tumors, Monolayer, and Spheroid Tissue Culture Environments in Malignant Melanoma and Breast Carcinoma


Tumor Cells
10.1007/s00018-019-03222-1

Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis


Tumor Cells
10.15789/1563-0625-2019-2-221-230

НЕКОТОРЫЕ АСПЕКТЫ ИСПОЛЬЗОВАНИЯ АЛЛО- И КСЕНОГРАФТНЫХ МОДЕЛЕЙ ПРИ РАЗРАБОТКЕ ПРОТИВОРАКОВЫХ ВАКЦИН И ОНКОЛИТИЧЕСКИХ ВИРУСОВ


Tumor Cells
10.3390/md17040244

A Novel Peptide from Abalone (Haliotis discus hannai) to Suppress Metastasis and Vasculogenic Mimicry of Tumor Cells and Enhance Anti-Tumor Effect In Vitro


Tumor Cells
10.1097/MD.0000000000016579

The predictive values of serum dickkopf-1 and circulating tumor cells in evaluating the efficacy of transcatheter arterial chemoembolization treatment on hepatocellular carcinoma


Tumor Cells
10.1007/s10555-019-09825-1

Progress toward liquid biopsies in pediatric solid tumors


Tumor Cells
10.1016/j.ymthe.2018.09.016

Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.


Tumor Cells
10.1002/ijc.32323

BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype


Tumor Cells
10.3390/cancers11081056

Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma


Tumor Cells
10.5582/bst.2019.01326

The pro-tumor effect and the anti-tumor effect of neutrophils extracellular traps.


Tumor Cells
10.1073/pnas.1804407116

The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation


Tumor Cells
10.1136/ijgc-2019-ESGO.89

P26 Micrometastasis in sentinel lymph nodes is a significant negative prognostic marker in early-stage cervical cancer


Tumor Cells
10.1158/1538-7445.AM2019-3075

Abstract 3075: Antitumor activity of M8891, a potent and reversible inhibitor of methionine aminopeptidase 2


Tumor Cells
10.1158/1538-7445.AM2019-1642

Abstract 1642: Spatial proteomics with hyperplexed fluorescence imaging predicts risk of colorectal cancer recurrence and infers recurrence-specific protein-protein networks


Highly Related Keywords of Tumor Cells